Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41–60 years

References

• Bacci G, Ferrari S, Donati D, Longhi A, Bertoni F, Di Fiore M, Comandone A, Cesari M, Campanacci M. Neoadjuvant chemotherapy for osteosarcoma of the extremity in patients in the fourth and fifth decade of life. Oncol Rep 1998; 5: 51259–63
   Google Scholar
• Bacci G, Ferrari S, Mercuri M, Longhi A, Capanna R, Tienghi A, Brach del Prever A, Comandone A, Cesari M, Bernini G, Picci P. Neoadjuvant chemotherapy for extremity osteosarcoma—preliminary results of the Rizzoli's 4th study. Acta Oncol 1998; 37(1)41–8
   PubMed Web of Science ®Google Scholar
• Bacci G, Ferrari S, Bretoni F, Ruggieri P, Picci P, Longhi A, Casadei R, Fabbri N, Forni C, Versari M, Campanacci M. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Riz-zoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol 2000; 18(24)4016–27
   PubMed Web of Science ®Google Scholar
• Bacci G, Ferrari S, Longhi A, Picci P, Mercuri M, Alvegard T A, Saeter G, Donati D, Manfrini M, Lari S, Briccoli A, Forni C. Italian Sarcoma Group/Scandinavian Sarcoma Group. High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandina-vian Sarcoma Group pilot study. J Chemother 2002; 14: 2198–206
   Google Scholar
• Carsi B, Rock M G. Primary osteosarcoma in adults older than 40 years. Clin Orthop 2002; 397: 53–61
   PubMed Web of Science ®Google Scholar
• Enneking W F. A system for the evaluation of the surgical management of musculoskeletal tumors. Limb salvage in musculoskeletal oncology, W F Enneking. Churchill Livingstone, New York 1987; 113: 187–91
   Google Scholar
• Fuchs N, Bielack S S, Epler D, Bieling P, Delling G, Korholz D, Graf N, Heise U, Jurgens H, Kotz R, Salzer-Kuntschik M, Weinel P, Werner M, Winkler K. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998; 9(8)893–9
   PubMed Web of Science ®Google Scholar
• Gobel V, Jurgens H, Etspuler G, Kemperdick H, Jungblut R M, Stienen U, Gobel U. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol 1987; 113: 2187–91
   Google Scholar
• Greditzer H G, 3rd, McLeod R A, Unni K K, Beabout J W. Bone sarcomas in Paget disease. Radiology 1983; 146(2)327–33
   PubMedGoogle Scholar
• Grimer R J, Cannon S R, Taminiau A M, Bielack S, Kempf-Bielack B, Windhager R, Dominkus M, Saeter G, Bauer H, Meller I, Szendroi M, Folleras G, San-Julian M, van der Eijken J. Osteosarcoma over the age of forty. Eur J Cancer 2003; 39(2)157–63
   PubMed Web of Science ®Google Scholar
• Hryniuk W, Bush H. The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 1984; 2(11)1281–8
   PubMed Web of Science ®Google Scholar
• Huvos A G. Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years. Cancer 1986; 57(7)1442–9
   PubMed Web of Science ®Google Scholar
• Huvos A G, Woodard H Q, Cahan W G, Higinbotham N L, Stewart F W, Butler A, Bretsky S S. Postradiation osteogenic sarcoma of bone and soft tissues. A clinicopathologic study of 66 patients. Cancer 1985; 55: 61244–55
   Google Scholar
• Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 2006; 32(6)423–36
   PubMed Web of Science ®Google Scholar
• Marina N, Gebhardt M, Teot L, Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 2004; 9(4)422–41
   PubMed Web of Science ®Google Scholar
• Meyers P A, Heller G, Healey J, Huvos A, Lane J, Marcove R, Applewhite A, Vlamis V, Rosen G. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992; 10(1)5–15
   PubMed Web of Science ®Google Scholar
• Mirra R. Bone tumors. Lea & Fabiger, London-Philadelphia 1989; 2: 255–6
   Google Scholar
• Naka T, Fukuda T, Shinohara N, Iwamoto Y, Sugioka Y, Tsuneyoshi M. Osteosarcoma versus malignant fibrous histiocytoma of bone in patients older than 40 years. A clinicopathologic and immunohistochemical analysis with special reference to malignant fibrous histiocytomalike osteosarcoma. Cancer 1995; 76(6)972–84
   PubMedGoogle Scholar
• Picci P, Bacci G, Campanacci M, Gasparini M, Pilotti S, Cerasoli S, Bertoni F, Guerra A, Capanna R, Albisinni U, Galletti S, Gherlinzoni F, Calderoni P, Sudanese A, Baldini N, Bernini M, Jaffe N. Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy Regional mapping of viable and nonviable tumor. Cancer 1985; 56(7)1515–21
   PubMedGoogle Scholar
• Provisor A J, Ettinger L J, Nachman J B, Krailo M D, Makley J T, Yunis E J, Huvos A G, Betcher D L, Baum E S, Kisker C T, Miser J S. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1997; 15(1)76–84
   PubMed Web of Science ®Google Scholar
• Rosen G, Caparros B, Huvos A G, Kosloff C, Nirenberg A, Cacavio A, Marcove R C, Lane J M, Mehta B, Urban C. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49: 61221–30
   Google Scholar
• Winkler K, Beron G, Kotz R, Salzer-Kuntschik M, Beck J, Beck W, Brandeis W, Ebell W, Erttmann R, Gobel U, Havers W, Henze G, Hinderfeld L, Hocker P, Jobke A, Jurgens H, Kabish H, Preusser P, Prindull G, Ramach W, Ritter J, Sekera J, Treuner J, Wust G, Landbeck G. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study. J Clin Oncol 1984; 2(6)617–24
   PubMed Web of Science ®Google Scholar
• Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purfurst C, Berger J, Ritter J, Jurgens H, Gerein V, Graf N, Russe W, Gruemayer E R, Ertelt W, Kotz R, Preusser P, Prindull G, Brandeis W, Landbeck G. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988; 6(2)329–37
   PubMed Web of Science ®Google Scholar